IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q1 2025 Holdings

Filed 2025-04-03 | 3 holdings | $13.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kyverna Therapeutics, Inc.(KYTX)Common Stock501976104$8.7M4,523,92464.0%
Allogene Therapeutics, Inc.(ALLO)Common Stock019770106$2.6M1,798,16319.3%
Kronos Bio, Inc.(KRON1USD)Common Stock50107A104$2.3M2,765,31416.7%